Nuclear Medicine: Page 409

AMI brings two organizations under its wing
By AuntMinnie.com staff writers
The Academy of Molecular Imaging has merged with the Society of Non-Invasive Imaging in Drug Development (SNIDD) and High Resolution Imaging in Small Animals (HiRes).
April 2, 2002
Positron issues "going concern" warning
By AuntMinnie.com staff writers
PET manufacturer Positron's independent auditor has expressed substantial doubt as to the firm's ability to continue as a going concern.
April 1, 2002
Mobile PET inks deal with BUPA
By AuntMinnie.com staff writers
Mobile PET Systems has signed an agreement with the British United Provident Organization (BUPA).
March 31, 2002
CTI signs deal with Zmed
By AuntMinnie.com staff writers
PET developer CTI of Knoxville, TN, plans to improve the DICOM connectivity of its PET scanners through an agreement with medical technology firm Zmed of Ashland, MA.
March 24, 2002
Cytogen to bring ProstaScint to Canada
By AuntMinnie.com staff writers
Pharmaceutical firm Cytogen has received a notice of compliance from Health Canada for its ProstaScint prostate cancer imaging agent, allowing the Princeton, NJ-based vendor to begin selling the radiolabeled monoclonal antibody agent in Canada.
March 17, 2002
DraxImage brings production in-house
By AuntMinnie.com staff writers
DraxImage has received FDA approval to manufacture lyophilized products at its in-house facility.
March 13, 2002
SNM names executive director
The Society of Nuclear Medicine has appointed Virginia Pappas as executive director.
March 6, 2002
Necessity criteria compliance critical for PET reimbursement
Are you thinking about developing PET as a modality that your practice will offer? CSI President Melody Mulaik explains Medicare’s medical necessity criteria and guidelines to ensure the financial viability of your venture.
February 27, 2002
2001 11 16 10 13 24 706
P.E.T. Net expands US Oncology supply deal
By AuntMinnie.com staff writers
P.E.T.Net Pharmaceuticals has expanded its exclusive supply agreement with US Oncology.
February 26, 2002
Neoprobe reports second year of profitability
By AuntMinnie.com staff writers
Radiopharmaceutical probe developer Neoprobe of Dublin, OH, eked out a net profit for its 2001 financial results (end-December 31).
February 24, 2002
Guilford names new president and CEO
Radiopharmaceutical developer Guilford Pharmaceuticals has named David Wright as president and chief business officer.
February 24, 2002
Philips, Theseus team up
By AuntMinnie.com staff writers
Philips Medical Systems and North American Scientific subsidiary Theseus Imaging are collaborating to research and develop improved methodology for noninvasive imaging of cardiac cell death.
February 20, 2002
Previous Page
Page 409 of 439
Next Page